Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2000
11/29/2000EP1054685A1 Liquid crystal forms of cyclosporin
11/29/2000EP1054674A2 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/29/2000EP1054667A1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents
11/29/2000EP1054664A1 Method for modulating macrophage activation
11/29/2000EP1054591A1 Improved extracorporeal methods for enhancing antigen presentation and immune responsiveness
11/29/2000EP0863905B1 imidazole lipoxygenase inhibitors
11/29/2000EP0749323B1 Methods for modulating t cell anergy
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000CN1275162A Death domain containing receptor 5
11/29/2000CN1275128A Pyrazolo (3,4-D) pyrimidines with anticonvulsive and antialiergic/antiasthmatic action
11/29/2000CN1275085A Cytolysis of target cell, reagent and composition for cytolysis and compound for preparing these reagents
11/29/2000CN1275084A Recombinant porcine adenovirus vector
11/29/2000CN1275080A Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/29/2000CN1058968C Novel pyrido [3,2-e] pyrazinones with anti-asthmatic action and process for their manufacture
11/29/2000CN1058964C Branched-amino-sbustituted thiazoles, process for their preparation and the pharmaceutical compositions which contain them
11/29/2000CN1058880C Compound antibacterial and antiviral veterinary medicine capable of raising immunity
11/29/2000CN1058873C Chinese medicine for curing deficiency of vital energy
11/28/2000US6153754 Process for production of piperidine derivatives
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153641 Pharmaceutically active compounds
11/28/2000US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153615 Administering nitric oxide synthesis inhibiting amount of dihydrofolate reductase inhibitor, catecholamine replacing non-toxic amount of levodopa with or without carbidopa and serotonin replacing non-toxic amount of l-5-hydroxytryptophane
11/28/2000US6153605 Useful in treatment or prevention of vitamin d dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure
11/28/2000US6153601 Polyholoside compositions for stimulating the immune system
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/28/2000US6153203 Immunological tolerance-inducing agent
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153195 Method of delivering drugs to cells specific for an HL-60 lectin
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070043A1 Recombinant human mannan-binding lectin
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070025A1 Methods of using rnase p reaction mechanisms of action
11/23/2000WO2000069898A2 Molecular interactions in allergy cells
11/23/2000WO2000069897A2 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/23/2000WO2000069896A2 Molecular interactions in haematopoietic cells
11/23/2000WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069868A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
11/23/2000WO2000069860A1 Imidazo-containing heterocyclic compounds, their compositions and uses
11/23/2000WO2000069859A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000WO2000069855A2 Furanone derivatives as inhibitors of cathepsin s
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069838A1 Ion channel modulating agents
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069818A1 MORPHOLINO-N-ETHYL ESTER DERIVATIVE OF AN INDOLE sPLA2 INHIBITOR
11/23/2000WO2000069815A1 Ureido-substituted cyclic amine derivatives and their use as drug
11/23/2000WO2000069458A2 Adjuvant combinations for immunization composition and vaccines
11/23/2000WO2000069457A1 Protein a based binding domains with desirable activities
11/23/2000WO2000069456A2 Adjuvant combination formulations
11/23/2000WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000WO2000069439A1 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
11/23/2000WO2000069426A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO2000043371A3 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
11/23/2000WO2000038706A3 Methods for treating cancer and for mediating chemotaxis of dendritic cells
11/23/2000WO2000037067A9 Sensitizing agents for the treatment of skin lesions
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000030681A9 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
11/23/2000WO2000023053A3 Artificial antigen-specific cells and related methods
11/23/2000WO2000004863A3 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/23/2000WO1999061398A3 24-hydroxyvitamin d, analogs and uses thereof
11/23/2000DE19922462A1 New phenylureidobenzyl-substituted spiro-imidazolidinedione derivatives, are inhibitors of leukocyte adhesion or migration or VLA-4 receptors, useful e.g. for treating inflammatory or allergic disease
11/23/2000DE10024788A1 Substance for increasing an immune response during vaccinations or for increasing the production of antibodies, comprises solid lipid particles of a specific size and charge
11/23/2000CA2767116A1 Adjuvant combination formulations
11/23/2000CA2374559A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000CA2374297A1 Furanone derivatives as inhibitors of cathepsin s
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374013A1 Protein a based binding domains with desirable activities
11/23/2000CA2373824A1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373532A1 Morpholino-n-ethyl ester derivative of an indole spla2 inhibitor
11/23/2000CA2373500A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372549A1 Ox2 receptor homologs
11/23/2000CA2372435A1 Recombinant human mannan-binding lectin
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000CA2372200A1 Self-assembling biomolecular structures
11/23/2000CA2372128A1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000CA2372068A1 Sulphostin analogue and process for producing sulphostin and its analogue
11/23/2000CA2372051A1 Imidazo-containing heterocyclic compounds, their compositions and uses
1 ... 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 ... 1172